Content

Welcome to the CJU website » LOG IN

Details

Erectile dysfunction and hypogonadism (low testosterone)
Humber River Regional Hospital, University of Toronto, Toronto, Ontario, Canada
Apr 2011 (Vol. 18, Issue 21, Pages( 2 - 7)
PMID: 21501544

Abstract

Text-Size + 

  • Erectile dysfunction (ED) is one of the earliest signs and markers of present or potential future endothelial dysfunction. One of the causes of ED can be low testosterone levels or hypogonadism. This article describes ways to identify and diagnose patients with ED or hypogonadism, and it offers a plan for treatment of these conditions. The mainstay first-line medical therapies for ED are phosphodiesterase-5 (PDE-5) inhibitors. For patients with symptomatic hypogonadism, testosterone replacement therapy is both safe and effective.

Current Issue

August 2017, Vol.24 No.4
canadian journal of urology mobile

canadian journal of urology